Post-transplant hemolytic-uremic syndrome

被引:44
作者
Ruggenenti, P
Noris, M
Cohen, JJ
Schieppati, A
Remuzzi, G
Perico, N
Zoja, C
Gregorini, G
Galbusera, M
机构
[1] Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy
[2] Osped Riuniti Bergamo, Azienda Osped, I-24100 Bergamo, Italy
关键词
Shiga toxin; thrombocytopenia; cyclosporine; tacrolimus; total-body irradiation; graft-versus-host disease; thrombotic microangiopathy;
D O I
10.1046/j.1523-1755.2002.00543.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1093 / 1104
页数:12
相关论文
共 74 条
[21]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[22]   A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow [J].
Galbusera, M ;
Remuzzi, A ;
Benigni, A ;
Rossi, C ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (04) :695-702
[23]   Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions [J].
Gallego, MJ ;
Zoja, C ;
Morigi, M ;
Micheletti, G ;
Imberti, B ;
Foppolo, M ;
Remuzzi, A ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :23-31
[24]  
GALLI FC, 1993, J HEART LUNG TRANSPL, V12, P440
[25]   DECREASE IN ENDOTHELIAL CELL-DEPENDENT PROTEIN-C ACTIVATION INDUCED BY THROMBOMODULIN BY TREATMENT WITH CYCLOSPORINE [J].
GARCIAMALDONADO, M ;
KAUFMAN, CE ;
COMP, PC .
TRANSPLANTATION, 1991, 51 (03) :701-705
[26]   APPARENT RECURRENCE OF HEMOLYTIC UREMIC SYNDROME IN AZATHIOPRINE-TREATED ALLOGRAFT RECIPIENTS [J].
GRINO, JM ;
CARALPS, A ;
CARRERAS, L ;
NOGUES, R ;
CASTELAO, AM ;
ROMERO, R ;
CARRERAS, M ;
ALSINA, J .
NEPHRON, 1988, 49 (04) :301-304
[27]   Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation - is tacrolimus the answer? [J].
Grupp, C ;
Schmidt, F ;
Braun, F ;
Lorf, T ;
Ringe, B ;
Muller, GA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1629-1631
[28]   POSTTRANSPLANTATION OUTCOME OF PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME - UPDATE [J].
HEBERT, D ;
KIM, EM ;
SIBLEY, RK ;
MAUER, MS .
PEDIATRIC NEPHROLOGY, 1991, 5 (01) :162-167
[29]  
HEBERT D, 1992, HEMOLYTIC UREMIC SYN, P179
[30]   TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY - THE ROLE OF IGG ADMINISTRATION AS INITIAL THERAPY [J].
HOCHSTETLER, LA ;
FLANIGAN, MJ ;
LAGER, DJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (03) :444-450